SCHEMBL15909047

SCHEMBL15909047

C[C@]1(NC(=O)c2cccc(F)c2)CC[C@@H]2CN(Cc3ccccc3)C[C@@H]21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.48
MEN1 O00255 2/20 0.48
CYP2D6 P10635 4/20 0.47
MAPK1 P28482 1/20 0.47
TSHR P16473 1/20 0.46
DRD2 P14416 2/20 0.44
DRD4 P21917 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 2/20 0.44
TP53 P04637 1/20 0.44
RECQL P46063 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
HPGD P15428 1/20 0.43
CCR2 P41597 1/20 0.42
GRIN2B Q13224 1/20 0.42
NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15908932 1.00 KMT2A (0.48) KMT2AMEN1CYP2D6MAPK1TSHR
SCHEMBL37562 1.00 KMT2A (0.48) KMT2AMEN1CYP2D6MAPK1TSHR
SCHEMBL15908943 0.90 DRD4 (0.44) KMT2AMEN1CYP2D6MAPK1TSHR
SCHEMBL37325 0.90 DRD4 (0.44) KMT2AMEN1CYP2D6MAPK1TSHR
SCHEMBL37324 0.90 DRD4 (0.44) KMT2AMEN1CYP2D6MAPK1TSHR
SCHEMBL38609 0.81 GRIN2B (0.42) KMT2AMEN1CYP2D6DRD2DRD4
SCHEMBL15908954 0.81 GRIN2B (0.42) KMT2AMEN1CYP2D6DRD2DRD4
SCHEMBL37731 0.81 GRIN2B (0.42) KMT2AMEN1CYP2D6DRD2DRD4
SCHEMBL15908962 0.77 L3MBTL1 (0.47) KMT2AMEN1CYP2D6NPC1RAB9A
SCHEMBL37968 0.77 L3MBTL1 (0.47) KMT2AMEN1CYP2D6NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110294854-A1 SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS ABBOTT LABORATORIES (US) 2011-12-01 US claimed
US-8796470-B2 Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators ABBVIE INC. (US) 2014-08-05 US disclosed
US-20110294854-A1 SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS ABBOTT LABORATORIES (US) 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294854-A1 SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS ORAI1, CACNA1E, RYR1 KMT2A 3756/4885MEN1 2180/4885CYP2D6 1002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.